heart 1481125922

CardiNor inks US distribution agreement with IBL-America for the CardiNor Secretoneurin ELISA test

Cardiovascular DX company CardiNor AS has signed an exclusive agreement with IBL-America for sales of the CardiNor Secretoneurin ELISA test in the US. By initially targeting research institutes, clinical research organisations and pharmaceutical companies, CardiNor aims to spread awareness of this important new frontline biomarker and pave the way for future commercialisation upon US regulatory […]

fujifilm Digital pathology

Fujifilm commits to digital pathology

Fujifilm is at the forefront of the digital histopathology revolution, centred around the Dynamyx software by Inspirata, and supported by partnerships that drive improvements in patient care.

Olympus Provi CM20 1

Olympus Provi CM20 wins highest honour in Red Dot Design Award

The Olympus Provi CM20 incubation monitoring system has won the prestigious “Best of the Best” award in the Product Design category of the 2022 Red Dot Design Award. This Award is bestowed on a product that the Red Dot Jury deems as groundbreaking and is the highest honour given in this world-renowned design competition.

ProteoNic

ProteoNic licenses 2G UNic technology platform for production of biologics to FyoniBio

ProteoNic, a leading provider of premium vector technology and services for production of biologics, and FyoniBio, a contract development organization for biopharmaceuticals, have entered into a technology licensing agreement. Under the agreement, FyoniBio gains worldwide, non-exclusive commercial rights for application of ProteoNic techno-logy in its proprietary CHOnamite platform. As a result, FyoniBio’s clients will profit […]

MIC

Microchip Imaging Cytometry set to make quantitative lab testing more economical, easy-to-use, and accessible

Scientific and technical advances in the field of Microchip Imaging Cytometry (MIC) are set to advance quantitative diagnostic testing that may deliver more economical, easy-to-use, and accessible healthcare to the public, according to a new article published in Opto-Electronic Advances [1].

cannabis

Existing drug tests can detect delta-8-THC – the latest cannabis craze

As the cannabis derivative delta-8-THC grows in popularity, it’s important for drug tests to be able to detect and differentiate it from delta-9-THC – the primary psychoactive ingredient in cannabis. Breaking research showcased at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo demonstrates that common drug testing methods can do just that.

shutterstock 2021617082

Innovative tests may resolve challenges in children’s healthcare

A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time. Findings on this method and a second innovative test that could improve diagnosis of paediatric urinary tract infections (UTIs) were discussed at the 2022 AACC Annual […]

shutterstock 2083276144

New research could reduce healthcare disparities based on race when diagnosing kidney disease

New research shows that removing a race modifier from a formula used to diagnose kidney disease could lead to more equitable care for Black patients. This study and a second that examines how this same diagnostic approach impacts Asian patients was presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.

AACC logo

Theranos whistleblowers and experts on AI and genomic sequencing draw nearly 17,000 attendees to 2022 AACC Annual Scientific Meeting

AACC welcomed thousands of medical professionals and healthcare leaders to the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo at the McCormick Place Convention Center in Chicago from July 24-28. The meeting featured ground-breaking diagnostic advances that will help solve challenging patient health problems, and affirmed just how essential laboratory medicine professionals are to […]

EUROLabPolaris klein

New automation technologies at the vanguard of IFA diagnostics

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. Continuing this long tradition, the company has over the last year introduced further groundbreaking products to increase the efficiency and standardization of indirect immunofluorescence assay (IFA) analyses. CLI talked to Dr Panagiotis Grypiotis, Head of Product Management Autoimmune Diagnostics, Endocrinology/Biologics and Automation […]